Moderna (LTS:0A45) Accumulated other comprehensive income (loss) : $-101 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Moderna Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Moderna's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was $-101 Mil.

Moderna's quarterly Accumulated other comprehensive income (loss) increased from Sep. 2023 ($-211 Mil) to Dec. 2023 ($-123 Mil) and increased from Dec. 2023 ($-123 Mil) to Mar. 2024 ($-101 Mil).

Moderna's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($-24 Mil) to Dec. 2022 ($-370 Mil) but then increased from Dec. 2022 ($-370 Mil) to Dec. 2023 ($-123 Mil).

Moderna Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Moderna's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Accumulated other comprehensive income (loss) Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

1.80

3.00

-24.00

-370.00

-123.00

Moderna Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-267.00	-263.00	-211.00	-123.00	-101.00

Moderna Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Moderna Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Moderna's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna (LTS:0A45) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (LTS:0A45) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Peru MRNA:Mexico 0QFd:UK 0QF:Germany M1RN34:Brazil MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna (LTS:0A45) Headlines

No Headlines